{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:15:25Z","timestamp":1758705325040,"version":"3.44.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009499","name":"University of Nebraska","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013116","name":"University Committee on Research and Creative Activity","doi-asserted-by":"publisher","award":["NIH GM103427"],"award-info":[{"award-number":["NIH GM103427"]}],"id":[{"id":"10.13039\/100013116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bioorg.2020.103590","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:11:59Z","timestamp":1580123519000},"page":"103590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Activity of diphenyl ether benzyl amines against Human African Trypanosomiasis"],"prefix":"10.1016","volume":"97","author":[{"given":"James P.","family":"Hagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Darner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek A.","family":"Leas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Mashinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasloach","family":"Wol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vera-Esquivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret","family":"Belter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Cal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Wallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie C.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2020.103590_b0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Aromatic diamidines as antiparasitic agents","volume":"30","author":"Patterson","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2020.103590_b0010","unstructured":"HAT factsheet, WHO, Jan 2017. WHO website http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/ (accessed February 2017)."},{"key":"10.1016\/j.bioorg.2020.103590_b0015","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1371\/journal.pntd.0001695","article-title":"Safety and efficacy of the 10-Day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness","volume":"6","author":"Kuepfer","year":"2012","journal-title":"Plos Neglect. Trop. Dis."},{"key":"10.1016\/j.bioorg.2020.103590_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2020.103590_b0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.bioorg.2020.103590_b0030","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/C7MD00280G","article-title":"Novel lead compounds in pre-clinical development against African sleeping sickness","volume":"8","author":"Berninger","year":"2017","journal-title":"Med. Chem. Commun."},{"issue":"10","key":"10.1016\/j.bioorg.2020.103590_b0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human african trypanosomiasis","volume":"34","author":"Baker","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2020.103590_b0040","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/AAC.02309-13","article-title":"In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness","volume":"58","author":"Wenzler","year":"2014","journal-title":"Antimicrob. Age. Chemother."},{"key":"10.1016\/j.bioorg.2020.103590_b0045","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/13543784.14.8.957","article-title":"Aromatic diamidines as antiparasitic agents","volume":"14","author":"Soeiro","year":"2005","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2020.103590_b0050","first-page":"147","article-title":"Diamidines as antitrypanosomal, antileishmanial and antimalarial agents","volume":"7","author":"Werbovetz","year":"2006","journal-title":"Curr. Opin. Investig. Drugs (Thomson Scientific)"},{"issue":"8","key":"10.1016\/j.bioorg.2020.103590_b0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0031182013000292","article-title":"Novel amidines and analogues as promising agents against intracellular parasites: a systematic review","volume":"140","author":"Soeiro","year":"2013","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/j.bioorg.2020.103590_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"Thuita","year":"2008","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103590_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004363","article-title":"Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial","volume":"10","author":"Pohlig","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2020.103590_b0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40262-014-0136-3","article-title":"Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies","volume":"53","author":"Tarral","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bioorg.2020.103590_b0075","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/results?term=Fexinidazole&Search=Search (accessed October 7, 2016)."},{"issue":"12","key":"10.1016\/j.bioorg.2020.103590_b0080","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2020.103590_b0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jac\/dkv417","article-title":"Pentacyclic nitrofurans that rapidly kill nifurtimox-resistant Trypanosomes","volume":"71","author":"Bruhn","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2020.103590_b0090","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1021\/jm301687p","article-title":"Optimization of chloronitrobenzamides (CNBs) as therapeutic leads for human african trypanosomiasis (HAT)","volume":"56","author":"Hwang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0095","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2015.08.014","article-title":"Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation","volume":"23","author":"Papadopoulou","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/id500034v","article-title":"Antiprotozoal selectivity of diimidazoline N-phenylbenzamides","volume":"1","author":"Wang","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103590_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/ml100013s","article-title":"Discovery of novel benzoxaborole-based potent antitrypanosomal agents","volume":"1","author":"Ding","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103590_b0110","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pntd.0001151","article-title":"SCYX-7158, an orally active benzoxaborole for the treatment of stage 2 human African trypanosomiasis","volume":"5","author":"Jacobs","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2020.103590_b0115","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01533961?term=SCYX-7158&rank=1 (accessed October 7, 2016)."},{"issue":"4","key":"10.1016\/j.bioorg.2020.103590_b0120","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1128\/AAC.02490-15","article-title":"Activity of bisnaphthalimidopropyl derivatives against Trypanosoma brucei","volume":"60","author":"Gra\u00e7a","year":"2016","journal-title":"Antimicrob. Age. Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2020.103590_b0125","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.01667-15","article-title":"In Vitro and In Vivo trypanosomicidal action of novel arylimidamides against Trypanosoma cruzi","volume":"60","author":"Guedes-da-Silva","year":"2016","journal-title":"Antimicrob. Age. Chemother."},{"issue":"8","key":"10.1016\/j.bioorg.2020.103590_b0130","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/AAC.01757-15","article-title":"Quinolone amides as antitrypanosomal lead compounds with In Vivo activity","volume":"60","author":"Georg Hiltensperger","year":"2016","journal-title":"Antimicrob. Age. Chemother."},{"key":"10.1016\/j.bioorg.2020.103590_b0135","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.bmc.2016.04.006","article-title":"Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense","volume":"24","author":"Patrick","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0140","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1021\/acs.jmedchem.6b00442","article-title":"Hit-to-lead optimization of a novel class of potent, broad-spectrum trypanosomacides","volume":"59","author":"Russell","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0145","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/acsmedchemlett.7b00230","article-title":"1-Benzyl-3-aryl-2-thiohydantoin derivatives as new anti-Trypanosoma brucei agents: SAR and in vivo efficacy","volume":"8","author":"Buchynskyy","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2020.103590_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000506","article-title":"Adenosine kinase of T. b. rhodesiense identified as the putative target of L-[5-(L-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics","volume":"3","author":"Kuettel","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2020.103590_b0155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/jm901852f","article-title":"Synthesis and biological evaluation of botulinum neurotoxin A protease inhibitors","volume":"53","author":"Li","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0160","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/acs.jmedchem.5b00253","article-title":"Tailored near-infrared contrast agents for image guided surgery","volume":"58","author":"Costyl","year":"2015","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103590_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/ol702689v","article-title":"(BDP) CuH: A \u201cHot\u201d Stryker's reagent for use in achiral conjugate reductions","volume":"10","author":"Baker","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2020.103590_b0170","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/jm00111a043","article-title":"Verapamil analogues with restricted molecular flexibility","volume":"34","author":"Dei","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0175","unstructured":"A. Itai, Preparation of Piperazinyl Benzothiazoles as HDL Increasing Agents, October 9, 2008."},{"issue":"14","key":"10.1016\/j.bioorg.2020.103590_b0180","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/jo00408a041","article-title":"Rapid chromatographic technique for preparative separation with moderate resolution","volume":"43","author":"Still","year":"1978","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0185","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense","volume":"4","author":"Baltz","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2020.103590_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro","volume":"68","author":"R\u00e4z","year":"1997","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2020.103590_b0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of the three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"issue":"11","key":"10.1016\/j.bioorg.2020.103590_b0200","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/AAC.40.11.2592","article-title":"Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase","volume":"40","author":"Buckner","year":"1996","journal-title":"Antimicrob. Age. Chemother."},{"key":"10.1016\/j.bioorg.2020.103590_b0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Age. Chemother."},{"key":"10.1016\/j.bioorg.2020.103590_b0210","series-title":"Immunological Methods","first-page":"221","article-title":"Plasmodium falciparum malaria parasite cultures and their use in immunology","author":"Matile","year":"1990"},{"key":"10.1016\/j.bioorg.2020.103590_b0215","first-page":"50","article-title":"Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture","volume":"33","author":"Ponnudurai","year":"1981","journal-title":"Trop. Geogr. Med."},{"key":"10.1016\/j.bioorg.2020.103590_b0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/md8010047","article-title":"Inhibitory activity of marine sponge-derived natural products against parasitic protozoa","volume":"8","author":"Orhan","year":"2010","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.bioorg.2020.103590_b0225","first-page":"473","article-title":"A new fluorimetric assay for cytotoxicity measurements in vitro","volume":"3","author":"Page","year":"1993","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioorg.2020.103590_b0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H] thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Meth."},{"issue":"11","key":"10.1016\/j.bioorg.2020.103590_b0235","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1021\/jo960057x","article-title":"Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures","volume":"61","author":"Abdel-Magid","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3987\/COM-08-11516","article-title":"Synthesis and biological evaluation of inhibitors of botulinum neurotoxin metalloprotease","volume":"79","author":"Wang","year":"2009","journal-title":"Heterocycles"},{"key":"10.1016\/j.bioorg.2020.103590_b0245","unstructured":"Maria-Jesus Blanco-Pillado, Mark Chappell, Garcia De la Torre Marta Donald, Nuria Diaz Buezo, J.E. Fritz, W.G. Holloway, J.E. Matt Jr., C.H. Mitch, C. Pedregal-Tercero, S.J. Quimby, et al., From PCT Int. Appl., 2004, WO 2004026305 A1 20040401."},{"key":"10.1016\/j.bioorg.2020.103590_b0250","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/jm00111a043","article-title":"Verapamil analogue with restricted molecular flexibility","volume":"34","author":"Dei","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103590_b0255","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1021\/jm200363d","article-title":"Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies","volume":"54","author":"Deng","year":"2011","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2020.103590_b0260","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/0040-4020(79)87035-0","article-title":"A Rapid, Simple, and Mild Procedure for Alkylation of Phenols, Alcohols, Amides and Acids","volume":"35","author":"Johnstone","year":"1979","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2020.103590_b0265","unstructured":"A. Bozzoli, C.L. Branch, H. Marshall, D.J. Nash, Patent Application Country: Application: WO; WO; Priority Application Country: GB Patent WO2006002956, 2006."},{"key":"10.1016\/j.bioorg.2020.103590_b0270","unstructured":"C. Wang, Synthetic studies on haouamine A and other biologically active heterocycles, No Corporate Source data available, 2010, pp. 349."},{"key":"10.1016\/j.bioorg.2020.103590_b0275","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1021\/jo00042a037","article-title":"Tertiary carbinamines by addition of organocerium reagents to nitriles and ketimines","volume":"57","author":"Ciganek","year":"1992","journal-title":"J. Org. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103590_bib276","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1550-7408.1977.tb00987.x","article-title":"New culture medium for maintenance of tsetse tissues and growth of trypanosomatids.","volume":"22","author":"Cunnigham","year":"1977","journal-title":"J. Protozool."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103590_b9000","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parint.2017.10.010","article-title":"Novel Toxoplasma gondii inhibitor chemotypes","volume":"67","author":"Sanford","year":"2018","journal-title":"Parasitol. Int."},{"issue":"3","key":"10.1016\/j.bioorg.2020.103590_b9005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijpddr.2018.11.001","article-title":"Derivatives of a benzoquinone acyl hydrazone with activity against Toxoplasma gondii","volume":"8","author":"Sanford","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681931421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:03:21Z","timestamp":1758614601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520681931421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":58,"alternative-id":["S004520681931421X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103590","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of diphenyl ether benzyl amines against Human African Trypanosomiasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103590"}}